Regulation and legislation

Will the FSA-validated novel food submission list reveal commercially sensitive information?

11th March 2021 - Blogs |

There’s been some worry that the eventual list of brands with a novel food application validated by the UK Food Standards Agency (FSA) will reveal commercially sensitive information such as which brands are currently contracted to which ingredient or white-label goods suppliers. But the FSA has not indicated that such information would be included in any list. And there is » Continue Reading.

How long will it take to see validated assessments from the UK Food Standards Agency (FSA)?

4th March 2021 - Blogs |

The FSA has confirmed to CBD-Intel that it has already validated at least one application with an updated list to be published in April. This represents a significantly quicker turnaround than many anticipated, though Pureis did submit its application as soon as possible – telling CBD-Intel that it filed it one minute after midnight on 1st January 2021. However assuming » Continue Reading.

Could the Biden administration bring a new approach to enforcement of CBD health claims?

26th February 2021 - Blogs |

There is a chance that enforcement priorities could change under new appointments to the Federal Trade Commission (FTC) by the Biden administration. Two commissioners – one of which is staying on to work as part of the Republican minority of the five-commissioner panel in charge of the FTC, and the other of which appears to have some influence on their likely » Continue Reading.

Have the rules changed for importation of CBD into the UK?

18th February 2021 - Blogs |

The Home Office has not changed licensing requirements for importers of CBD into the UK. The minister for policing, Christopher “Kit” Malthouse, has requested an updated recommendation from the Advisory Council on the Misuse of Drugs (ACMD) on acceptable THC levels in CBD consumer products. The ACMD has not yet responded and the previous limit of 1 mg generic tolerance for » Continue Reading.

Podcast: are changes to the Philippine’s regulatory framework likely in the near future?

17th February 2021 - Podcasts , Resources |

Our host for today’s podcast is Jon Bruford, a copy editor at CBD-Intel, who will be joined by CBD-Intel junior legal analyst Elsa Carrasco, who discusses the current regulatory framework in place for CBD and cannabis in the Philippines. Elsa presents a clear idea of the legal framework of the country,  the requirements to operate in the CBD industry in » Continue Reading.

Will the EFSA look to modify its approach in light of action on novel food in the UK?

12th February 2021 - Blogs |

The European Food Safety Authority (EFSA) has stated that it is in contact with other similar agencies such as the Food Standards Agency (FSA) in the UK, but only specified that it would not treat applications that had been approved in other jurisdictions any differently during its own assessment process. But beyond that, it has not stated what other influence the FSA » Continue Reading.

Regulatory report: Canada, February 2021

8th February 2021 - Regulatory reports |

Canada permits the cultivation, production, distribution, and sale of hemp, cannabis, and products derived from them, but only by those licensed to do so by the government. This report offers a detailed overview of the rules

How seriously should producers of CBD alcohol products take the recent Portman Group ruling?

5th February 2021 - Blogs |

The Portman Group’s first decision on a complaint regarding a CBD product has gone largely unreported but could have a very significant impact on that part of the market. The voluntary alcohol industry regulator has said it is bringing out further guidance for producers of CBD alcoholic beverages – the first time it will have addressed the issue. So it is important to » Continue Reading.

European CBD Landscape 2021 and Beyond – Markets, Products & Consumers Trends

2nd February 2021 - Presentations , Resources |

CBD-Intel’s managing director, Tim Phillips, recently presented on the major global factors seen in the CBD industry in 2020, key pricing and product evolution throughout the year, and what to expect in 2021 during the GCI Virtual Summit. Tim analyses the shifts in consumer preferences and business developments – as well as challenges and opportunities of the sector. You can » Continue Reading.

What impact will the EC’s decision to permit the use of extracts from the whole plant in cosmetics have on the industry as a whole?

28th January 2021 - Blogs |

The decision – which should be noted is still only preliminary, though almost certainly to be confirmed with subsequent updating of the cosmetics ingredients (CosIng) database – should allow a wider range of cosmetic products onto the market. Exactly how much of an impact the change – when it eventually is confirmed – will make in reality largely depends on » Continue Reading.

Regulatory report: Philippines, January 2021

13th January 2021 - Regulatory reports |

A debate on regulating cannabis for medicinal use is on the table in the Philippines, and several bills are currently being discussed. This report provides an overview of the current regulatory regime for CBD and cannabis in the country

What impact do Democrat victories in both of the Georgia senate seat elections have on chances for cannabis reform at the US federal level?

8th January 2021 - Blogs |

President elect Joe Biden still looks to be somewhat reluctant to too closely embrace cannabis reform as an issue. But effective control of the senate through victories by Raphael Warnock and Jon Ossoff in special run-off elections in the state of Georgia give Democrats 48 seats with two independents that generally vote democratic (and would certainly do so on most » Continue Reading.